Form 8-K - Current report:
SEC Accession No. 0001654954-25-000918
Filing Date
2025-01-29
Accepted
2025-01-29 17:00:17
Documents
16
Period of Report
2025-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbsv_8k.htm   iXBRL 8-K 24173
2 PRESS RELEASE pbsv_ex991.htm EX-99.1 5438
  Complete submission text file 0001654954-25-000918.txt   141785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20250129.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20250129_lab.xml EX-101.LAB 12568
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20250129_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20250129_pre.xml EX-101.PRE 7857
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20250129_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_8k_htm.xml XML 3381
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

EIN.: 200653570 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-50956 | Film No.: 25570172
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)